Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randy Gascoyne

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Leukemia & Lymphoma|September 7, 2010
Targeting the microenvironmentJohn Gribben, Andreas Rosenwald, Randy Gascoyne, et al.
Leukemia & Lymphoma|October 23, 2002
Treatment of elderly Hodgkin's lymphoma patients with a novel 5-drug regimen (ODBEP): a phase II studyNicol Macpherson, Richard J Klasa, Randy Gascoyne, et al.
Genome Research|June 23, 2009
Circos: an information aesthetic for comparative genomicsMartin Krzywinski, Jacqueline Schein, Inanç Birol, et al.
Cancer Research|November 13, 2003
Aberrant expression of T-plastin in Sezary cellsMing-wan Su, Irene Dorocicz, Wieslawa H Dragowska, et al.
Journal of Huntington'S Disease|November 28, 2022
Huntingtin Overexpression Does Not Alter Overall Survival in Murine Cancer ModelsLaura Lynn Chan, Austin Hill, Ge Lu, et al.
Cancer|June 19, 2009
Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: report of the pivotal phase 2 studyM A Rodriguez, Robert Pytlik, Tomas Kozak, et al.
Blood|September 22, 2009
Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 studySandra J Horning, Malik E Juweid, Heiko Schöder, et al.
Leukemia & Lymphoma|October 19, 2007
Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: final results of E1497Timothy M Kuzel, Shuli Li, John Eklund, et al.
British Journal of Haematology|April 1, 2015
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404)Lode J Swinnen, Hailun Li, Andrew Quon, et al.
Haematologica|September 15, 2018
Bianca Schuhmacher, Julia Bein, Tobias Rausch, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Leukemia & Lymphoma|September 7, 2010
Targeting the microenvironmentJohn Gribben, Andreas Rosenwald, Randy Gascoyne, et al.
Leukemia & Lymphoma|October 23, 2002
Treatment of elderly Hodgkin's lymphoma patients with a novel 5-drug regimen (ODBEP): a phase II studyNicol Macpherson, Richard J Klasa, Randy Gascoyne, et al.
Genome Research|June 23, 2009
Circos: an information aesthetic for comparative genomicsMartin Krzywinski, Jacqueline Schein, Inanç Birol, et al.
Cancer Research|November 13, 2003
Aberrant expression of T-plastin in Sezary cellsMing-wan Su, Irene Dorocicz, Wieslawa H Dragowska, et al.
Journal of Huntington'S Disease|November 28, 2022
Huntingtin Overexpression Does Not Alter Overall Survival in Murine Cancer ModelsLaura Lynn Chan, Austin Hill, Ge Lu, et al.
Cancer|June 19, 2009
Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: report of the pivotal phase 2 studyM A Rodriguez, Robert Pytlik, Tomas Kozak, et al.
Blood|September 22, 2009
Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 studySandra J Horning, Malik E Juweid, Heiko Schöder, et al.
Leukemia & Lymphoma|October 19, 2007
Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: final results of E1497Timothy M Kuzel, Shuli Li, John Eklund, et al.
British Journal of Haematology|April 1, 2015
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404)Lode J Swinnen, Hailun Li, Andrew Quon, et al.
Haematologica|September 15, 2018
Bianca Schuhmacher, Julia Bein, Tobias Rausch, et al.
Pageof 2